1995
DOI: 10.1159/000176876
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac and Carotid Structure in Arterial Hypertension and in Hypertrophic Cardiomyopathy

Abstract: The aim of this study was to measure intima-media thickness (IMT) of the common carotid artery (CCA) in patients with hypertrophic cardiomyopathy (HCM) and in hypertensive patients with left ventricular hypertrophy (LVH). We studied 73 subjects: 20 normotensive healthy subjects as control group (I); 20 patients with essential hypertension without LVH (II); 20 hypertensives with LVH (III), and 13 normotensive patients with HCM (IV). Each subject underwent a complete echocardiographic and vascular ultrasonograph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

1997
1997
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 13 publications
0
2
0
1
Order By: Relevance
“…32 The hypertensive patients with LVH showed structural alterations (related to hemodynamic and humoral factors) both at cardiac and vascular level, while in patients with HCM the cardiac alterations (due to a genetic disorder) were not associated with changes at the level of the large arteries. 33 Martinez-Diaz et al 34 have studied 3 types of cardiomyopathy to observe the expression and assess the significance of different immunohistochemical markers (muscular actin, CD-31, proliferation cell nuclear antigen (PCNA)-, Ki-67, and markers related with programmed cell death, bcl-2, p-53, and apopDETEC) of 40 cases: 10 each of HHC, HCM, HCM in patients treated with chemotherapy and morphologically ''normal'' hearts. Their findings point to an absence of structural marker expression (actin and CD-31) in cases of hypoxic damage.…”
Section: Neurohumoral and Genetic Profilesmentioning
confidence: 99%
“…32 The hypertensive patients with LVH showed structural alterations (related to hemodynamic and humoral factors) both at cardiac and vascular level, while in patients with HCM the cardiac alterations (due to a genetic disorder) were not associated with changes at the level of the large arteries. 33 Martinez-Diaz et al 34 have studied 3 types of cardiomyopathy to observe the expression and assess the significance of different immunohistochemical markers (muscular actin, CD-31, proliferation cell nuclear antigen (PCNA)-, Ki-67, and markers related with programmed cell death, bcl-2, p-53, and apopDETEC) of 40 cases: 10 each of HHC, HCM, HCM in patients treated with chemotherapy and morphologically ''normal'' hearts. Their findings point to an absence of structural marker expression (actin and CD-31) in cases of hypoxic damage.…”
Section: Neurohumoral and Genetic Profilesmentioning
confidence: 99%
“…large arteries. 17 Endothelial dysfunction assessed based on the changes in either peripheral vascular resistance or the vessel diameter during acetylcholine administration has been used as a sensitive marker of atherosclerosis. 18,19 In our study, we found that in patients with HCM, endothelial-dependent or independent vasodilatation did not differ from that observed in healthy subjects.…”
Section: Desensitization Of Vascular Adrenoceptorsmentioning
confidence: 99%
“…Die arterielle Hypertonie ist neben dem Alter der am stärksten mit einer Verdickung der IntimaMedia-Dicke einhergehende Risikofaktor [5]. Eine medikamentöse antihypertensive Therapie verzö-gert die jährliche Progression der Intima-MediaDicke bei Patienten mit Hypertonie nach einer Metaanalyse von Wang et al [33] um -0,007 mm gegenüber den Kontrollen.…”
unclassified